Raj K. Puri
Chief Regulatory Officer at Iovance Biotherapeutics · 11 reported transactions in 1 company · latest report Sep 8, 2026
Their record
Across their whole record, 1 purchase can be measured; 1 did better than the S&P 500 over the next 6 months.
Typical move +35.4%, S&P 500 +16.0% over the same days.
Their trades
Shares withheld for tax | Sep 8, 2026 | |||
Exercised options | Sep 8, 2026 | |||
Shares withheld for tax | Jun 1, 2026 | |||
Exercised options | Jun 1, 2026 | |||
Shares withheld for tax | Dec 1, 2025 | |||
Exercised options | Dec 1, 2025 | |||
Shares withheld for tax | Sep 2, 2025 | |||
Exercised options | Sep 2, 2025 | |||
Shares withheld for tax | Jun 2, 2025 | |||
Exercised options | Jun 2, 2025 |